Raymond James Reiterates Outperform on CME Group, Maintains $320 Price Target

Benzinga Newsdesk www.benzinga.com Negative 89.3%

Neg 89.3% Neu 0% Pos 0%

Raymond James analyst Patrick O'Shaughnessy reiterates CME Group (NASDAQ:CME) with a Outperform and maintains $320 price target.